{
    "clinical_study": {
        "@rank": "119571", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      Determine whether copies of the cystic fibrosis gene (pGT-1) can be delivered to the cells\n      lining the nose of cystic fibrosis patients using cationic liposome (DMRIE/DOPE) mediated\n      gene transfer."
        }, 
        "brief_title": "Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer", 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Under direct visualization, patients receive lipid/DNA formulation (pGT-1\n      lipid complex) by syringe instillation over 30 minutes to the right inferior nasal\n      turbinate.\n\n      Patients are followed daily for 7 days, twice a week for 3 weeks, every 2-3 weeks for 10\n      weeks, then every 3 months thereafter."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Cystic fibrosis patients\n\n          -  Not pregnant Fertile patients must use effective contraception"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": "9", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004471", 
            "org_study_id": "199/13941", 
            "secondary_id": [
                "UAB-6097", 
                "UAB-F930923001"
            ]
        }, 
        "intervention": {
            "intervention_name": "pGT-1 gene lipid complex", 
            "intervention_type": "Genetic"
        }, 
        "keyword": [
            "cardiovascular and respiratory diseases", 
            "cystic fibrosis", 
            "genetic diseases and dysmorphic syndromes", 
            "rare disease"
        ], 
        "lastchanged_date": "March 28, 2011", 
        "overall_official": {
            "affiliation": "University of Alabama at Birmingham", 
            "last_name": "Eric J. Sorscher", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "May 2001", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004471"
        }, 
        "source": "University of Alabama at Birmingham", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Alabama at Birmingham", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 1995", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2011"
    }, 
    "geocoordinates": {}
}